The first Intercept Pharmaceuticals trade was made in Q2 2014.
Since then Steven Cohen bought shares fourteen more times and sold shares on twelve occasions. The investor completely sold their stake between Q4 2022 and Q1 2023.
Avg closing price
Price range
Sold -166 Thousand shares
Q1 2023
Avg closing price
$17.30
Price range
$12.53
-
$21.71
Sold 89.3% shares (-1.39 Million shares)
Q4 2022
Avg closing price
$14.16
Price range
$11.61
-
$16.11
Increased shares by 1124.8% (+1.43 Million shares)
Q3 2022
Avg closing price
$16.10
Price range
$12.21
-
$19.70
Increased shares by 66.4% (+50.8 Thousand shares)
Q2 2022
Avg closing price
$16.01
Price range
$11.23
-
$19.59
Sold 85.1% shares (-438 Thousand shares)
Q1 2022
Avg closing price
$15.66
Price range
$13.37
-
$17.79
Sold 26.4% shares (-185 Thousand shares)
Q4 2021
Avg closing price
$16.86
Price range
$14.28
-
$19.53
New holding (+699 Thousand shares)
Q3 2021
Avg closing price
$16.00
Price range
$12.99
-
$20.47
Sold -648 Thousand shares
Q2 2019
Avg closing price
$89.50
Price range
$77.77
-
$120.68
Increased shares by 708.3% (+568 Thousand shares)
Q1 2019
Avg closing price
$109.26
Price range
$91.83
-
$120.68
New holding (+80.2 Thousand shares)
Q4 2018
Avg closing price
$103.65
Price range
$85.79
-
$126.46
Sold -282 Thousand shares
Q2 2018
Avg closing price
$73.22
Price range
$60.00
-
$85.67
Increased shares by 925.1% (+254 Thousand shares)
Q1 2018
Avg closing price
$60.27
Price range
$52.72
-
$67.25
Sold 52.2% shares (-30 Thousand shares)
Q4 2017
Avg closing price
$63.06
Price range
$58.20
-
$72.76
Sold 79.9% shares (-228 Thousand shares)
Q3 2017
Avg closing price
$107.71
Price range
$57.01
-
$135.03
Increased shares by 29.5% (+65 Thousand shares)
Q2 2017
Avg closing price
$115.83
Price range
$105.62
-
$132.29
Increased shares by 13.1% (+25.5 Thousand shares)
Q1 2017